Virpax Pharmaceuticals Inc. - Rasio total nilai perusahaan marang pendapatan VRPX

Logo perusahaan publik Virpax Pharmaceuticals (VRPX)

Innovative non-opioid analgesic delivery methods are creating a key growth driver for Virpax Pharmaceuticals. The change in the enterprise value-to-revenue multiple visualizes this trend, where shows the level of this metric. Prospects are supported by hospital demand for safe therapy and the management's scientific foundation, although the company's financial stability depends on the periodic raising of external capital.

Virpax Pharmaceuticals - Rasio nilai perusahaan marang pendapatan VRPX (periode 04.07.2022 - 20.11.2026)

Rincian metrik keuangan lan pasar Virpax Pharmaceuticals Inc. (VRPX)

- rega saham lan prakiraan rega para ahli:
- informasi babagan dhuwit lan arus kas:
Pambiji fundamental:Virpax VRPX
Produk seri Virpax Pharmaceuticals, Inc.

To filter investment risks, it is essential to understand how the market values a business relative to its operating income. This indicator is calculated as the ratio of enterprise value (EV) to revenue; however, the revenue-based valuation of Virpax Pharmaceuticals (VRPX) remains speculative due to the absence of current sales during the clinical development stage.